CN106214862B - A kind of Traditional Chinese veterinary medicine oral solution and preparation method thereof preventing and treating the atypical newcastle disease of chicken - Google Patents
A kind of Traditional Chinese veterinary medicine oral solution and preparation method thereof preventing and treating the atypical newcastle disease of chicken Download PDFInfo
- Publication number
- CN106214862B CN106214862B CN201610695005.XA CN201610695005A CN106214862B CN 106214862 B CN106214862 B CN 106214862B CN 201610695005 A CN201610695005 A CN 201610695005A CN 106214862 B CN106214862 B CN 106214862B
- Authority
- CN
- China
- Prior art keywords
- parts
- chicken
- radix
- newcastle disease
- traditional chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000003814 drug Substances 0.000 title claims abstract description 63
- 241000287828 Gallus gallus Species 0.000 title claims abstract description 58
- 229940100688 oral solution Drugs 0.000 title claims abstract description 38
- 208000010359 Newcastle Disease Diseases 0.000 title claims abstract description 35
- 238000002360 preparation method Methods 0.000 title claims abstract description 15
- 229940079593 drug Drugs 0.000 claims abstract description 23
- 230000002265 prevention Effects 0.000 claims abstract description 21
- 239000009636 Huang Qi Substances 0.000 claims abstract description 12
- 241000219099 Parthenocissus quinquefolia Species 0.000 claims abstract description 12
- 235000009388 Parthenocissus quinquefolia Nutrition 0.000 claims abstract description 12
- 241000205407 Polygonum Species 0.000 claims abstract description 12
- 244000307697 Agrimonia eupatoria Species 0.000 claims abstract description 11
- 241001660870 Cyrtomium Species 0.000 claims abstract description 11
- 239000010231 banlangen Substances 0.000 claims abstract description 11
- 235000000125 common agrimony Nutrition 0.000 claims abstract description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 11
- 239000000470 constituent Substances 0.000 claims abstract description 3
- 239000000706 filtrate Substances 0.000 claims description 21
- 239000002994 raw material Substances 0.000 claims description 17
- 239000012141 concentrate Substances 0.000 claims description 16
- 230000000694 effects Effects 0.000 claims description 9
- 238000000034 method Methods 0.000 claims description 8
- 238000002156 mixing Methods 0.000 claims description 6
- 238000001914 filtration Methods 0.000 claims description 4
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 claims description 4
- 235000010234 sodium benzoate Nutrition 0.000 claims description 4
- 239000004299 sodium benzoate Substances 0.000 claims description 4
- 238000005303 weighing Methods 0.000 claims description 3
- 238000007654 immersion Methods 0.000 claims description 2
- 244000144977 poultry Species 0.000 abstract description 5
- 230000001684 chronic effect Effects 0.000 abstract description 3
- 239000003640 drug residue Substances 0.000 abstract description 2
- 235000013330 chicken meat Nutrition 0.000 description 49
- 238000012360 testing method Methods 0.000 description 28
- 210000001161 mammalian embryo Anatomy 0.000 description 20
- 241000711404 Avian avulavirus 1 Species 0.000 description 15
- 208000032843 Hemorrhage Diseases 0.000 description 14
- 230000000740 bleeding effect Effects 0.000 description 14
- 210000004369 blood Anatomy 0.000 description 9
- 239000008280 blood Substances 0.000 description 9
- 201000010099 disease Diseases 0.000 description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 9
- 239000013641 positive control Substances 0.000 description 9
- 210000004072 lung Anatomy 0.000 description 8
- 238000010790 dilution Methods 0.000 description 7
- 239000012895 dilution Substances 0.000 description 7
- 210000002784 stomach Anatomy 0.000 description 7
- BITDLWAQPKSXTF-UHFFFAOYSA-M 1-[(3-nitrophenyl)methoxymethyl]pyridin-1-ium;chloride Chemical compound [Cl-].[O-][N+](=O)C1=CC=CC(COC[N+]=2C=CC=CC=2)=C1 BITDLWAQPKSXTF-UHFFFAOYSA-M 0.000 description 6
- 206010007247 Carbuncle Diseases 0.000 description 6
- 206010011224 Cough Diseases 0.000 description 6
- 208000025865 Ulcer Diseases 0.000 description 6
- 210000002216 heart Anatomy 0.000 description 6
- 238000011081 inoculation Methods 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 210000004185 liver Anatomy 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 230000004083 survival effect Effects 0.000 description 6
- 231100000397 ulcer Toxicity 0.000 description 6
- 206010012735 Diarrhoea Diseases 0.000 description 5
- 206010023126 Jaundice Diseases 0.000 description 5
- 210000003837 chick embryo Anatomy 0.000 description 5
- 235000013601 eggs Nutrition 0.000 description 5
- 210000000952 spleen Anatomy 0.000 description 5
- 208000024891 symptom Diseases 0.000 description 5
- 241000196324 Embryophyta Species 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- 208000002193 Pain Diseases 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 238000009835 boiling Methods 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- 239000003651 drinking water Substances 0.000 description 4
- 235000020188 drinking water Nutrition 0.000 description 4
- 210000000232 gallbladder Anatomy 0.000 description 4
- 230000003067 hemagglutinative effect Effects 0.000 description 4
- 241000411851 herbal medicine Species 0.000 description 4
- 238000010079 rubber tapping Methods 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 210000002700 urine Anatomy 0.000 description 4
- 206010017553 Furuncle Diseases 0.000 description 3
- 241000700605 Viruses Species 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 230000004907 flux Effects 0.000 description 3
- 230000023597 hemostasis Effects 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 235000013594 poultry meat Nutrition 0.000 description 3
- 244000025254 Cannabis sativa Species 0.000 description 2
- 206010018612 Gonorrhoea Diseases 0.000 description 2
- 208000000616 Hemoptysis Diseases 0.000 description 2
- 206010027514 Metrorrhagia Diseases 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 206010053615 Thermal burn Diseases 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 230000000840 anti-viral effect Effects 0.000 description 2
- 238000009361 aviculture Methods 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 238000005260 corrosion Methods 0.000 description 2
- 238000007405 data analysis Methods 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000000994 depressogenic effect Effects 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 229940000406 drug candidate Drugs 0.000 description 2
- 210000002257 embryonic structure Anatomy 0.000 description 2
- 206010015037 epilepsy Diseases 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 235000021050 feed intake Nutrition 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 208000003512 furunculosis Diseases 0.000 description 2
- 208000001786 gonorrhea Diseases 0.000 description 2
- 230000035931 haemagglutination Effects 0.000 description 2
- 208000021760 high fever Diseases 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 210000004347 intestinal mucosa Anatomy 0.000 description 2
- 201000004792 malaria Diseases 0.000 description 2
- 238000002483 medication Methods 0.000 description 2
- 229960002581 moroxydine hydrochloride Drugs 0.000 description 2
- 230000003387 muscular Effects 0.000 description 2
- 230000001114 myogenic effect Effects 0.000 description 2
- 210000002445 nipple Anatomy 0.000 description 2
- 210000002741 palatine tonsil Anatomy 0.000 description 2
- 206010033675 panniculitis Diseases 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 210000000697 sensory organ Anatomy 0.000 description 2
- 238000007619 statistical method Methods 0.000 description 2
- 210000004304 subcutaneous tissue Anatomy 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 230000008736 traumatic injury Effects 0.000 description 2
- 229960005486 vaccine Drugs 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 206010000234 Abortion spontaneous Diseases 0.000 description 1
- 206010000242 Abortion threatened Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 241000242722 Cestoda Species 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 206010014080 Ecchymosis Diseases 0.000 description 1
- 208000009701 Embryo Loss Diseases 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 206010016952 Food poisoning Diseases 0.000 description 1
- 208000019331 Foodborne disease Diseases 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- 206010018367 Glomerulonephritis chronic Diseases 0.000 description 1
- 241001415959 Grus japonensis Species 0.000 description 1
- 206010020565 Hyperaemia Diseases 0.000 description 1
- 208000019693 Lung disease Diseases 0.000 description 1
- 208000005647 Mumps Diseases 0.000 description 1
- 208000012902 Nervous system disease Diseases 0.000 description 1
- 208000025966 Neurological disease Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 208000030852 Parasitic disease Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 206010035148 Plague Diseases 0.000 description 1
- 208000005374 Poisoning Diseases 0.000 description 1
- 206010036790 Productive cough Diseases 0.000 description 1
- 208000004680 Rectal Fistula Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- IWUCXVSUMQZMFG-AFCXAGJDSA-N Ribavirin Chemical compound N1=C(C(=O)N)N=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 IWUCXVSUMQZMFG-AFCXAGJDSA-N 0.000 description 1
- 241000593989 Scardinius erythrophthalmus Species 0.000 description 1
- 206010039587 Scarlet Fever Diseases 0.000 description 1
- 241000207929 Scutellaria Species 0.000 description 1
- 208000004078 Snake Bites Diseases 0.000 description 1
- 208000005985 Threatened Abortion Diseases 0.000 description 1
- 206010070863 Toxicity to various agents Diseases 0.000 description 1
- 241001502500 Trichomonadida Species 0.000 description 1
- 206010046814 Uterine prolapse Diseases 0.000 description 1
- 206010046914 Vaginal infection Diseases 0.000 description 1
- 201000008100 Vaginitis Diseases 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 206010051373 Wound haemorrhage Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- 240000008866 Ziziphus nummularia Species 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- DKNWSYNQZKUICI-UHFFFAOYSA-N amantadine Chemical compound C1C(C2)CC3CC2CC1(N)C3 DKNWSYNQZKUICI-UHFFFAOYSA-N 0.000 description 1
- 229960003805 amantadine Drugs 0.000 description 1
- 206010002156 anal fistula Diseases 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 235000019636 bitter flavor Nutrition 0.000 description 1
- 208000034158 bleeding Diseases 0.000 description 1
- 210000000991 chicken egg Anatomy 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 238000003759 clinical diagnosis Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000019621 digestibility Nutrition 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 230000000762 glandular Effects 0.000 description 1
- 230000003862 health status Effects 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 201000005630 leukorrhea Diseases 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 210000003563 lymphoid tissue Anatomy 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 208000015994 miscarriage Diseases 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 210000004400 mucous membrane Anatomy 0.000 description 1
- 208000010805 mumps infectious disease Diseases 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 210000002394 ovarian follicle Anatomy 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 238000005498 polishing Methods 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 235000013613 poultry product Nutrition 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 201000010727 rectal prolapse Diseases 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 229960000329 ribavirin Drugs 0.000 description 1
- HZCAHMRRMINHDJ-DBRKOABJSA-N ribavirin Natural products O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1N=CN=C1 HZCAHMRRMINHDJ-DBRKOABJSA-N 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 208000000995 spontaneous abortion Diseases 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 206010046901 vaginal discharge Diseases 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/19—Acanthaceae (Acanthus family)
- A61K36/195—Strobilanthes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
- A61K36/315—Isatis, e.g. Dyer's woad
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/539—Scutellaria (skullcap)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Neurosurgery (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention belongs to field of traditional Chinese veterinary, particularly disclose a kind of Traditional Chinese veterinary medicine oral solution and preparation method thereof for preventing and treating the atypical newcastle disease of chicken.The Traditional Chinese veterinary medicine oral solution of the atypical newcastle disease of prevention and treatment chicken is using hairyvein agrimony, herba lysimachiae, Radix Isatidis, Radix Astragali, polygonum cuspidate, rhizome of cyrtomium, radix scutellariae, radix ampelopsis, Radix Glycyrrhizae as active constituent, it is made by certain parts by weight, dedicated for preventing and treating the chronic newcastle disease of chicken, it is significant in efficacy, can drink water medication, and poultry medication is convenient, degree of being absorbed and utilized height, drug residue free is of great significance to the green and healthy cultivation of guarantee poultry.
Description
Technical field
The invention belongs to field of traditional Chinese veterinary, in particular to a kind of Traditional Chinese veterinary medicine oral solution for preventing and treating the atypical newcastle disease of chicken and
Preparation method.
Background technique
Newcastle disease (ND) is that acute, the hot, septic of one kind of the fowl as caused by newcastle disease virus and high degree in contact pass
It catches an illness, illness has very high disease incidence characterized by high fever, expiratory dyspnea, diarrhea, neurological disorders, mucous membrane and serous coat bleeding
And case fatality rate, it is a kind of Infectious Diseases for endangering aviculture.With the generally use of vaccine, the typical newcastle disease of high mortality
Less generation, but with disease incidence 10%-30%, clinical symptoms are unobvious, pathological change is not true to type, the death rate is not high, lay eggs
The non typical newcastle disease that chicken egg drop reduction is characterized then repeated, and have brought tremendous economic losses to aviculture.
Newcastle disease mainly uses vaccine immunity to be prevented, and chicken group there is no specific treatment medicine, especially exist once falling ill
The antiviral Western medicine such as amantadine, Ribavirin disables after poultry in China, and the treatment of newcastle disease has become more outstanding
Problem.Chinese herbal medicine is a big treasure-house of China's traditional medicine, has the characteristics that Yin Yang balancing, eliminating pathogen to support vital qi, treating both manifestation and root cause of disease, positive day
Benefit becomes the hot spot of new antiviral drug research.Because Chinese medicine has, effect is unique, antiviral spectrum is wide, toxic side effect is small, significant in efficacy
The advantages that, many large size livestock and poultry cultivation enterprises make herbal medicine as the emphasis for preventing, treating disease and promotion growth of animal
Herbal medicine use with object, middle-size and small-size farm (family) is also increasingly extensive.With the continuous improvement of people's living standards, China
Apparent variation has occurred in people's diet structure, and green products of domestic animal is favored by market deeply.It solves to raise by herbal control
Western medicine residue problem in poultry product produces nontoxic, harmless animal products, becomes the inexorable trend of the following animal husbandry development.
Therefore, a kind of Chinese herbal medicine non typical newcastle disease according to caused by diagnosis and treatment based on an overall analysis of the illness and the patient's condition principle prevention and treatment exogenous disease plague is needed.
Summary of the invention
Reasonable simple, each composition proportion, good effect are prepared, without medicine the technical problem to be solved in the present invention is to provide a kind of
Residual, poultry is easy to absorption, the Traditional Chinese veterinary medicine oral solution of the prevention and treatment atypical newcastle disease of chicken easy to use and preparation method thereof.
The technical solution of the present invention is as follows:
It is a kind of prevent and treat the atypical newcastle disease of chicken Traditional Chinese veterinary medicine oral solution, active constituent by following parts by weight raw material
Be made: 10~30 parts of hairyvein agrimony, 10~30 parts of Radix Isatidis, 7~21 parts of Radix Astragali, 10~30 parts of polygonum cuspidate, is passed through at 12~36 parts of herba lysimachiae
Many 18~24 parts, 18~24 parts of radix scutellariaes, 7~21 parts of radix ampelopsis, 3~9 parts of Radix Glycyrrhizae.
The Traditional Chinese veterinary medicine oral solution of the atypical newcastle disease of prevention and treatment chicken, the weight proportion of preferred each raw material are as follows: red crowned crane
It is 20 parts of grass, 24 parts of herba lysimachiae, 20 parts of Radix Isatidis, 14 parts of Radix Astragali, 20 parts of polygonum cuspidate, 21 parts of rhizome of cyrtomium, 21 parts of radix scutellariae, 14 parts of radix ampelopsis, sweet
6 parts of grass.
The preparation method of the Traditional Chinese veterinary medicine oral solution of the atypical newcastle disease of prevention and treatment chicken, using following steps:
(1) each raw material mixing for weighing above-mentioned parts by weight is placed in Chinese medicine extracting tank, is added water to cook 2 times, specific side
Method are as follows: for the first time plus the water of 7 times of weight, immersion 1 hour are boiled 1 hour, and first-time filtrate is obtained after filtering;Second plus 3 times of weight
Water, boil 0.5 hour, after filtering secondary filtrate;
(2) merge first-time filtrate obtained and secondary filtrate in step (1), obtain merging filtrate;Merging filtrate is depressurized dense
It is reduced to every milliliter of concentrate and is equivalent to 1g crude drug, obtain concentrate;
(3) it will be added in concentrate made from step (2) and account for concentrate weight than the sodium benzoate for 0.3%, stirring is equal
The even Traditional Chinese veterinary medicine oral solution to get the prevention and treatment atypical newcastle disease of chicken.
Usage and dosage: daily 1ml/kg weight, drinking-water are used in conjunction 4-5 days.
The pharmacological property and pharmacology analysis of Chinese medicine material selected by the present invention are as follows:
Polygonum cuspidate: mildly bitter flavor, cold nature.Enter liver, gallbladder, lung three to pass through.It is clearing heat and detoxicating with removing dampness through diuresis and removing jaundice, removing blood stasis and acesodyne, cough-relieving
The function of resolving sputum.Cure mainly jaundice with damp-heat pathogen, stranguria with turbid discharge, leukorrhagia, rheumatic arthralgia, carbuncle sore tumefacting virus, scald, menostasis, abdominal mass, instep beats damage
Wound, cough with lung heat.
Hairyvein agrimony: it is bitter, puckery, it is mild-natured.Enter the heart, liver two passes through.With astringing to arrest bleeding, detoxification sore treatment, desinsection, puckery sweat, cough-relieving
Function.Cure mainly hemoptysis, spit blood, bleeding from five sense organs or subcutaneous tissue, hematuria, metrorrhagia and metrostaxis, bloody flux, malaria, diabete hidrosis, overstrain cough etc. diseases, control trichomonad outside
The diseases such as property vaginitis, furuncle sore carbuncle swells, hemorrhoid.
Radix Isatidis: bitter, it is cold in nature.Enter the heart, stomach two passes through.With clearing heat and detoxicating, cool blood, the function of relieving sore-throat.Poison when curing mainly warm epidemic disease,
Fever pharyngalgia, febrile virulent maculae, mumps, scarlet fever, major part pestilence, erysipelas, carbuncle swells.
Herba lysimachiae: sweet in flavor, salty, cold nature.Enter liver, gallbladder, kidney, bladder four to pass through.It is clearing heat and detoxicating with promoting diuresis for stranguria, dissipate the stasis of blood
Detumescence, eliminating dampness and heat, Sha Lin, urine is puckery to have a pain, jaundice and reddish urine, the function of carbuncle swells furunculosis.Cure mainly liver and gallbladder and stone in urinary system, heat gonorrhea,
Nephritic dropsy, jaundice with damp-heat pathogen, sore carbuncle swells, venomous snake bite, traumatic injury.
Radix Astragali: sweet in flavor, slightly warm in nature.Enter spleen, lung two passes through.Consolidate table, the function of torr sore myogenic with polishing.Physically weak spontaneous perspiration is cured mainly,
Chronic diarrhea, rectal prolapse, uterine prolapse, chronic nephritis, physically weak edema, chronic ulcer, the long disunion of the open sore part.
Rhizome of cyrtomium: bitter, it is slightly cold.Return liver, the spleen channel.With desinsection, heat-clearing, removing toxic substances, the function of cooling blood and hemostasis.Cure mainly wind-heat sense
It emits, warms ecchymosis, spit blood, hemoptysis, bleeding from five sense organs or subcutaneous tissue, hematochezia, metrorrhagia and metrostaxis, bloody flux, the intestinal parasitic diseases such as leukorrhagia and hook, ascarid, tapeworm.
Radix scutellariae: it is bitter, cold in nature, enter the heart, lung, gallbladder, large intestine channel.With excess fire is rushed down, except damp and hot, hemostasis, the function of miscarriage prevention.It cures mainly
High fever polydipsia, cough with lung heat, damp-heat dysentery, jaundice, heat gonorrhea are spat, are defeated in battle, collapse, are leaked, red eye, swell pain, threatened abortion, carbuncle swells furunculosis.
Radix ampelopsis: bitter, pungent, cold nature.Enter the heart, lung, liver, spleen four to pass through.With clearing heat and detoxicating, eliminating stagnation to stop pain, myogenic sore
Function.Treatment of ulcer pyogenic infections, scrofula, scald, wet sore, a kind of malaria, frightened epilepsy, bloody flux, intestines wind, anal fistula, leukorrhea, traumatic injury, wound
Bleeding.
Radix Glycyrrhizae: it is sweet in flavor, it is mild-natured.Enter the heart, lung, spleen, stomach four to pass through.With with middle emergency, moistening lung, removing toxic substances, the function of coordinating the drug actions of a prescription.
Cure mainly weakness of the spleen and the stomach, deficiency of food, abdominal pain loose stool, overstrain fever, consumptive lung disease cough, palpitaition, frightened epilepsy;It is raw to use, control abscess of throat, digestibility
Ulcer, ulcer sores solve poisoning of drug and food poisoning.
The present invention prevents and treats the Traditional Chinese veterinary medicine oral solution and preparation method thereof of the atypical newcastle disease of chicken, for the physiological status of chicken
And health status, by plurality of raw materials mix and match, scientific composition, it is main ingredient, hairyvein agrimony, plate that wherein polygonum cuspidate, radix scutellariae are clearing heat and detoxicating
Lan Gen, rhizome of cyrtomium, radix ampelopsis, herba lysimachiae cooling blood and hemostasis, eliminating stagnation to stop pain, eliminating dampness and heat are ministerial drug, and Radix Astragali invigorating qi for consolidating superficies are assistant, Radix Glycyrrhizae tune
It is to make with all medicines.Each raw material has complementary advantages, and using its mutual collaboration or resistant function, has clearing heat and detoxicating, eliminating dampness cool blood
The effect of, it can be used for the prevention and treatment of the atypical newcastle disease of chicken, good effect, no drug residue.
Specific embodiment
In order to which technical solution of the present invention is more clearly understood, with reference to embodiments, the present invention is carried out further
It is described in detail.
Embodiment 1:
The Traditional Chinese veterinary medicine oral solution of the atypical newcastle disease of prevention and treatment chicken, is made of the raw material of following weight:
20 kilograms of hairyvein agrimony, 24 kilograms of herba lysimachiae, 20 kilograms of Radix Isatidis, 14 kilograms of Radix Astragali, 20 kilograms of polygonum cuspidate, rhizome of cyrtomium 21,000
Gram, 21 kilograms of radix scutellariae, 14 kilograms of radix ampelopsis, 6 kilograms of Radix Glycyrrhizae;
The preparation method of the Traditional Chinese veterinary medicine oral solution of the atypical newcastle disease of prevention and treatment chicken, using following steps:
(1) each raw material (160 kilograms total) for weighing above-mentioned weight, puts into Chinese medicine extracting tank after mixing, Chinese medicine is added
The water (i.e. 1120 kilograms) that 7 times of raw material weight impregnates 1 hour, decocts, is kept for 1 hour after boiling, tapping filters once to filter
Liquid;The dregs of a decoction add 3 times of Chinese medicine material weight of water (i.e. 480 kilograms), decoct, are kept for 0.5 hour after boiling, tapping, filter
Obtain secondary filtrate;
(2) merge first-time filtrate obtained and secondary filtrate in step (1), obtain merging filtrate, be placed in efficient concentration device
It is concentrated under reduced pressure, medical fluid is concentrated into every milliliter of concentrate and is equivalent to 1g crude drug (i.e. 160 liters), obtains concentrate;
(3) it will be added in concentrate made from step (2) and account for concentrate weight than the sodium benzoate anti-corrosion for 0.3%, stirred
With the filling Traditional Chinese veterinary medicine oral solution to get the prevention and treatment atypical newcastle disease of chicken of 250ml plastic drug package after mixing uniformly.
Usage and dosage: daily 1ml/kg weight, drinking-water are used in conjunction 4-5 days.
Embodiment 2:
The Traditional Chinese veterinary medicine oral solution of the atypical newcastle disease of prevention and treatment chicken, is made of the raw material of following weight: hairyvein agrimony 30,000
Gram, 36 kilograms of herba lysimachiae, 30 kilograms of Radix Isatidis, 21 kilograms of Radix Astragali, 30 kilograms of polygonum cuspidate, 24 kilograms of rhizome of cyrtomium, 24 kilograms of radix scutellariae, radix ampelopsis
21 kilograms, 9 kilograms of Radix Glycyrrhizae;
Preparation method and usage and dosage are the same as embodiment 1.
Embodiment 3:
The Traditional Chinese veterinary medicine oral solution of the atypical newcastle disease of prevention and treatment chicken, is made of the raw material of following weight: hairyvein agrimony 10,000
Gram, 12 kilograms of herba lysimachiae, 10 kilograms of Radix Isatidis, 7 kilograms of Radix Astragali, 10 kilograms of polygonum cuspidate, 18 kilograms of rhizome of cyrtomium, 18 kilograms of radix scutellariae, radix ampelopsis 7
Kilogram, 3 kilograms of Radix Glycyrrhizae;
Preparation method and usage and dosage are the same as embodiment 1.
Embodiment 4:
The Traditional Chinese veterinary medicine oral solution of the atypical newcastle disease of prevention and treatment chicken, is made of the raw material of following weight: hairyvein agrimony 15,000
Gram, 18 kilograms of herba lysimachiae, 15 kilograms of Radix Isatidis, 10.5 kilograms of Radix Astragali, 15 kilograms of polygonum cuspidate, 19.5 kilograms of rhizome of cyrtomium, radix scutellariae 19.5 thousand
Gram, 10.5 kilograms of radix ampelopsis, 4.5 kilograms of Radix Glycyrrhizae;
Preparation method and usage and dosage are the same as embodiment 1.
Embodiment 5:
The Traditional Chinese veterinary medicine oral solution of the atypical newcastle disease of prevention and treatment chicken, is made of the raw material of following weight: hairyvein agrimony 25,000
Gram, 30 kilograms of herba lysimachiae, 25 kilograms of Radix Isatidis, 17.5 kilograms of Radix Astragali, 25 kilograms of polygonum cuspidate, 22.5 kilograms of rhizome of cyrtomium, radix scutellariae 22.5 thousand
Gram, 17.5 kilograms of radix ampelopsis, 7.5 kilograms of Radix Glycyrrhizae;
Preparation method and usage and dosage are the same as embodiment 1.
Test example (one):
Traditional Chinese veterinary medicine oral solution for the verifying present invention prevention and treatment atypical newcastle disease of chicken imitates the prevention and treatment of newcastle disease virus
Fruit, the In-vitro Inhibitory Effect of the present invention will be further illustrated by the following test examples oral solution to newcastle disease virus (NDV):
1 material
Experimental animal: 11 age in days SPF chicken embryos.
Virus: F48E8 plants of newcastle disease virus NDV, EID50It is 10-8.36/0.1mL。
Investigational agent: trial drug of the oral solution of 1-5 of embodiment of the present invention preparation as test example (one).
Comparison medicine: Moroxydine Hydrochloride, the production of Liaoning pharmacy head factory are made into the solution for standby of 0.1% concentration with PBS.
2 methods
2.1 egg inoculation
First use normal saline dilution at 200EID for F48E8 plants of NDV50Virus liquid, then by 1-5 system of the embodiment of the present invention
Each 1mL of standby oral solution is mixed in microcentrifugal tube with equivalent NDV dilution respectively, after 37 DEG C of water-bath effect 0.5h, respectively
It is inoculated with 11 age in days SPF chick embryo allantoic cavities, 0.2mL/ embryo, 10 pieces/group, as test group 1-5.
Physiological saline 1ml is mixed with equivalent NDV dilution, after 37 DEG C of water-bath 0.5h, the SPF chicken embryo urine of 11 ages in days of inoculation
Blister cavities, 0.2mL/ embryo, 10 pieces/group, as positive controls.
0.1% Moroxydine Hydrochloride solution 1ml is mixed with equivalent NDV dilution, 37 DEG C of water-bath 0.5h, 11 ages in days of inoculation
SPF chick embryo allantoic cavity, 0.2mL/ embryo, 10 pieces/group, as drug control group.
It after egg inoculation is complete, sets 37 DEG C of insulating boxs and is incubated for 96h, per a chicken embryo is checked for 24 hours, discard the dead germ in for 24 hours,
Survival chicken embryo is set 4 DEG C of refrigerators and is saved after dead germ and 96h after for 24 hours.Record chicken embryo death time and quantity.
2.2 hemagglutination tests: being carried out using micro-agglutination method, measures NDV hemagglutinative titer (HA) in every piece of chick embryo allantoic liquid.
The analysis of 2.3 data: data analysis is carried out to the chicken embryo survival rate of each group, hemagglutinative titer using SPSS software, is determined
Otherness between each group.
3 results
Chicken embryo is all survived after test 1-5 group 96 hours, Moroxydine Hydrochloride group and in positive controls chicken embryo 72 hours it is equal
It is all dead, statistical analysis show to test between 1-5 group chicken embryo survival rate and positive controls there are extremely significant difference (p <
0.01), and Moroxydine Hydrochloride group and positive control group difference be not significant (p > 0.05).From the point of view of HA titre, 1-5 group HA is tested
Titre is 0, positive controls 8.6, and Moroxydine Hydrochloride group is 7.8, and presence is extremely aobvious between test 1-5 group and positive controls
It writes difference (p<0.01), and Moroxydine Hydrochloride group and positive control group difference be not significant (p>0.05).Test result is detailed in table
1。
1 test example of table (one) chicken embryo test result
Experiments have shown that oral solution of the present invention in vitro significantly inhibits NDV proliferation.
Test example (two):
The interaction between each ingredient of Traditional Chinese veterinary medicine oral solution in order to verify the present invention prevention and treatment atypical newcastle disease of chicken,
It is further described below by way of test example.
1 material
Experimental animal: 11 age in days SPF chicken embryos.
Virus: F48E8 plants of newcastle disease virus NDV, EID50It is 10-8.36/0.1mL。
Investigational agent: oral solution and appoint from 1 oral solution, 9 kinds of raw materials of the embodiment of the present invention prepared by the embodiment of the present invention 1
Meaning choose it is one of, two kinds, three kinds, four kinds, five kinds, six kinds, seven kinds, eight kinds oral solution is made, as test example (two)
Test group drug.
2 methods
2.1 egg inoculation
First use normal saline dilution at 200EID for F48E8 plants of NDV50Virus liquid, then by test example (two) each test group
Each 1mL of drug is mixed in microcentrifugal tube with equivalent NDV dilution respectively, after 37 DEG C of water-bath effect 0.5h, is inoculated with 11 respectively
Age in days SPF chick embryo allantoic cavity, 0.2mL/ embryo, 10 pieces/group, as test group.
Physiological saline 1ml is mixed with equivalent NDV dilution, after 37 DEG C of water-bath 0.5h, the SPF chicken embryo urine of 11 ages in days of inoculation
Blister cavities, 0.2mL/ embryo, 10 pieces/group, as positive controls.
2.2 hemagglutination tests: being carried out using micro-agglutination method, measures NDV hemagglutinative titer (HA) in every piece of chick embryo allantoic liquid.
The analysis of 2.3 data: data analysis is carried out to the chicken embryo survival rate of each group, hemagglutinative titer using SPSS software, is determined
Otherness between each group.
3 results
Chicken embryo is all dead in positive controls 48 hours, and HA titre is 8.6;Oral solution group (1-1 prepared by embodiment 1
Group), chicken embryo is all survived, and HA titre is 0;2-1 group is to 2-27 group, and each group chicken embryo survival rate is between 10%~60%, HA
Titre is between 4.7~8.2.Statistical analysis shows oral solution group chicken embryo survival rate, HA titre and the positive prepared by embodiment 1
There are extremely significant difference (p < 0.01) between control group.From the point of view of test result, oral solution effect prepared by embodiment 1 is superior to it
Its each test group.
Wherein 28 groups of experimental result is now chosen to be described as follows:
Each test group oral liquid component in 2 test example of table (two)
Each test group drug of test example (two) the preparation method is as follows:
(1) each raw material is weighed, is put into Chinese medicine extracting tank after mixing, 7 times of Chinese medicine material weight of water is added, it is small to impregnate 1
When, it decocts, is kept for 1 hour after boiling, tapping filters to obtain first-time filtrate;The dregs of a decoction add 3 times of Chinese medicine material weight of water, decoct
It boils, is kept for 0.5 hour after boiling, tapping filters to obtain secondary filtrate;
(2) merge first-time filtrate obtained and secondary filtrate in step (1), obtain merging filtrate, be placed in efficient concentration device
It is concentrated under reduced pressure, medical fluid is concentrated into every milliliter of concentrate and is equivalent to 1g crude drug, obtains concentrate;
(3) it will be added in concentrate made from step (2) and account for concentrate weight than the sodium benzoate anti-corrosion for 0.3%, stirred
It is filling to get the test group oral solution with 250ml plastic drug package after mixing uniformly.
3 test example of table (two) chicken embryo test result
Experiments have shown that oral solution of the present invention significantly inhibits NDV proliferation, drug ratio is best, hence it is evident that excellent
In other each group drugs.
Application examples:
Case 1:
Jinan farm, wherein the blue brown laying hen more than 8000 in sea that a henhouse is raised is only, chicken group starts to send out when 230 age in days
Disease, diseased chicken spirit is depressed, and feed intake decline has respiratory symptom, draws green loose stool, and egg drop reduction is fragmentary daily dead.It cuts open
Inspection is died of illness chicken, glandular stomach nipple slight bleeding, muscular stomach cuticula ulcer, has bleeding spot under cuticula, entire enteron aisle diffusivity goes out
Blood, intestinal mucosa fall off, cecal tonsil swelling bleeding, the coronal fatty bleeding of cardiac muscle, tracheae hyperemia bleeding, ovarian follicle necrosis.According to
Clinical symptoms and dissect lesion, are diagnosed as atypical newcastle disease.Oral solution of the present invention is begun to use to be treated, every chicken is every
Its 1ml, 2 concentrations drinking-water medications of upper and lower noon point, is used in conjunction 5 days.After medication 3 days, chicken symptom starts to mitigate, and feed intake is significant
Increase, the 7th day after medication, chicken group restores normal completely.
Case 2:
Weifang raiser raises 817 Broiler chicks 10000, and when 41 age in days starts to fall ill, and chicken group's spirit is depressed, feeding
Amount decline, draws green loose stool, and individual chickens occur turn-taking, turn round the nervous symptoms such as neck, and dead more than 30 daily, dissect is died of illness chicken, gland
Stomach nipple slight bleeding, muscular stomach cuticula bleed bottom, intestinal mucosa bleeding, there is jujube core shape ulcer in some gut associated lymphatic tissues, blind
Intestinal tonsil body swelling bleeding, the heart are preced with fatty bleeding, and tunica mucosa tracheae bleeding is chronic newcastle disease through clinical diagnosis.Use this immediately
Invention oral solution is treated, the daily 0.5ml of every chicken, and 2 concentrations drinking-water medications of upper and lower noon point, chicken group is dead after being used in conjunction 5 days
Stop, spirit, appetite restore normal.
Claims (3)
1. a kind of Traditional Chinese veterinary medicine oral solution for preventing and treating the atypical newcastle disease of chicken, it is characterized in that: its active constituent is by following parts by weight
Several raw materials are made: 10~30 parts of hairyvein agrimony, 12~36 parts of herba lysimachiae, 10~30 parts of Radix Isatidis, 7~21 parts of Radix Astragali, polygonum cuspidate 10
~30 parts, 18~24 parts of rhizome of cyrtomium, 18~24 parts of radix scutellariae, 7~21 parts of radix ampelopsis, 3~9 parts of Radix Glycyrrhizae.
2. it is according to claim 1 prevention and treatment the atypical newcastle disease of chicken Traditional Chinese veterinary medicine oral solution, it is characterized in that: its activity at
Divide and be prepared from the following raw materials in parts by weight: 20 parts of hairyvein agrimony, 24 parts of herba lysimachiae, 20 parts of Radix Isatidis, 14 parts of Radix Astragali, polygonum cuspidate 20
Part, 21 parts of rhizome of cyrtomium, 21 parts of radix scutellariae, 14 parts of radix ampelopsis, 6 parts of Radix Glycyrrhizae.
3. a kind of preparation side of the Traditional Chinese veterinary medicine oral solution of the prevention and treatment atypical newcastle disease of chicken according to claim 1 to 2
Method, it is characterized in that: including the following steps:
(1) each raw material mixing for weighing above-mentioned parts by weight is placed in Chinese medicine extracting tank, is added water to cook 2 times, method particularly includes:
For the first time plus the water of 7 times of weight, immersion 1 hour are boiled 1 hour, and first-time filtrate is obtained after filtering;Add the water of 3 times of weight for the second time,
It boils 0.5 hour, secondary filtrate is obtained after filtering;
(2) merge first-time filtrate obtained and secondary filtrate in step (1), obtain merging filtrate;Merging filtrate is concentrated under reduced pressure into
Every milliliter of concentrate is equivalent to 1g crude drug, obtains concentrate;
(3) it will be added in concentrate made from step (2) and account for concentrate weight than the sodium benzoate for 0.3%, stirred evenly, i.e.,
Obtain the Traditional Chinese veterinary medicine oral solution of the prevention and treatment atypical newcastle disease of chicken.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610695005.XA CN106214862B (en) | 2016-08-18 | 2016-08-18 | A kind of Traditional Chinese veterinary medicine oral solution and preparation method thereof preventing and treating the atypical newcastle disease of chicken |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610695005.XA CN106214862B (en) | 2016-08-18 | 2016-08-18 | A kind of Traditional Chinese veterinary medicine oral solution and preparation method thereof preventing and treating the atypical newcastle disease of chicken |
Publications (2)
Publication Number | Publication Date |
---|---|
CN106214862A CN106214862A (en) | 2016-12-14 |
CN106214862B true CN106214862B (en) | 2019-10-25 |
Family
ID=57553288
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610695005.XA Active CN106214862B (en) | 2016-08-18 | 2016-08-18 | A kind of Traditional Chinese veterinary medicine oral solution and preparation method thereof preventing and treating the atypical newcastle disease of chicken |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106214862B (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109078065A (en) * | 2018-10-31 | 2018-12-25 | 衡阳市武顺循环农牧绿色生态科技有限公司 | A kind of drug and preparation method thereof for preventing and treating the mucosal checken pest of fowl |
CN109602795A (en) * | 2018-12-25 | 2019-04-12 | 北京鑫开元医药科技有限公司 | A kind of pharmaceutical composition and its extracting method, pharmaceutical preparation, purposes |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101816711A (en) * | 2009-11-16 | 2010-09-01 | 天津瑞贝特科技发展有限公司 | Effervescent Chinese medicinal composition for curing avian dysentery and preparation method thereof |
CN104288268A (en) * | 2013-07-16 | 2015-01-21 | 李振达 | Traditional Chinese medicinal formula for preventing and treating common diseases of chicken |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102008556B (en) * | 2009-09-08 | 2012-06-06 | 河南惠通天下动物药业有限公司 | Qiqing Baidu effervescent granule and preparation method thereof |
CN102698088B (en) * | 2012-01-05 | 2013-10-30 | 青岛华仁技术孵化器有限公司 | Traditional Chinese medicine composition for treating newcastle disease, feed, preparation method and application |
-
2016
- 2016-08-18 CN CN201610695005.XA patent/CN106214862B/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101816711A (en) * | 2009-11-16 | 2010-09-01 | 天津瑞贝特科技发展有限公司 | Effervescent Chinese medicinal composition for curing avian dysentery and preparation method thereof |
CN104288268A (en) * | 2013-07-16 | 2015-01-21 | 李振达 | Traditional Chinese medicinal formula for preventing and treating common diseases of chicken |
Also Published As
Publication number | Publication date |
---|---|
CN106214862A (en) | 2016-12-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102755505B (en) | Traditional Chinese medicinal herb mixture for preventing and treating new castle disease and production technology | |
CN103719560A (en) | Feed for preventing Newcastle disease | |
CN102961636B (en) | Pure traditional Chinese medicine composition for treating poultry infectious bursal disease and preparation method thereof | |
CN103191240B (en) | Traditional Chinese veterinary medicine oral solution for preventing and treating viral diseases of poultry | |
CN101972392A (en) | Chinese medicinal composition for treating chicken colibacillosis and preparation method thereof | |
CN106214862B (en) | A kind of Traditional Chinese veterinary medicine oral solution and preparation method thereof preventing and treating the atypical newcastle disease of chicken | |
CN104771686B (en) | A kind of Chinese medicine preparation for treating poultry ventriculitis proventriculitis and preparation method thereof | |
CN104547997B (en) | A kind of Chinese medicine composition for treating piglet epidemic diarrhea | |
CN103877229A (en) | Compound Chinese medicinal extract for preventing and controlling poultry colibacillosis and application thereof | |
CN102552657B (en) | Chinese medicinal composition used for treating Newcastle disease of chicken | |
CN103055206B (en) | Pure Chinese medicinal composition for treating chicken colibacillosis and pullorum disease and preparation method thereof | |
CN102727693B (en) | Compound propolis composition used for treating swine toxoplasmosis, and preparation method thereof | |
CN103861007B (en) | A kind of Chinese herbal compound preparation for the treatment of chicken diarrhea | |
CN103860890A (en) | Traditional Chinese medicine for treating chicken proventriculitis and ventriculitis | |
CN106377716A (en) | Traditional Chinese medicine composition for treating dysentery | |
CN101653473A (en) | Traditional Chinese medicine composition for treating chicken bursa fabricic and preparation method thereof | |
CN105558437A (en) | Additive for overwintering feed for metapenaeus ensis and preparation method | |
CN105582413A (en) | Pharmaceutical composition for preventing and treating piglet diarrhea and preparation method of pharmaceutical composition | |
CN108514622A (en) | A kind of Chinese medicine preparation and preparation method thereof for treating poultry ventriculitis proventriculitis | |
CN114099573B (en) | Traditional Chinese medicine composition for improving egg laying performance of laying hens as well as preparation method and application of traditional Chinese medicine composition | |
CN103623192B (en) | Medicine being used for the treatment of pig blue-ear disease and preparation method thereof | |
CN102743508B (en) | Compound propolis composition for treating avian infectious laryngotracheitis and preparation method thereof | |
CN103446410B (en) | Traditional Chinese medicine preparation for treating viral myocarditis | |
CN101947305A (en) | Traditional Chinese medicinal composition for treating virus disease and Escherichia coli mixed infection of poultry | |
CN107583023A (en) | Treat Chinese medicine preparation and the preparation of intestinal obstruction |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |